Mr Mrs Miss Ms Dr Other

Dr
Andrew
Wells

Partner & Head of Chemistry

Manchester Office Alderley Park Office

Chemistry

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 752 507 1499
Email. [email protected]

Experience

Andrew’s patent practice is principally in the pharmaceutical and chemical fields. He has extensive experience in securing patent protection for pharmaceuticals and specialises in drafting and prosecuting patent applications covering new chemical entities, salts, polymorphs, formulations (including advanced drug delivery technologies), manufacturing processes, medical uses, and medical devices. Outside of the pharmaceutical field, Andrew’s practice encompasses agrochemicals, polymer chemistry, petroleum additives, catalytic compositions, separation chemistry, adhesive technologies and biosensors.

Andrew acts for a diverse range of clients, including international corporations, universities, start-up companies and associate patent attorney firms based outside of the UK.

He commenced his patent career in private practice before joining the in-house patent department of a major multi-national pharmaceutical company in June 2004. As an in-house attorney, Andrew was responsible for the patent portfolios relating to a number of high priority drug development projects, as well as conducting IP due diligence evaluations to support in-licensing activities. Andrew returned to private practice in November 2008 when he joined the Manchester office of HGF as a Partner.

Andrew draws on both his private practice and in-house experience to provide commercially-focused advice to his clients in relation to all patent matters, including patent portfolio management, enforcing patent rights, challenging third party patent rights, providing infringement and validity opinions, and conducting due diligence evaluations to support licensing and acquisition deals. Andrew also has considerable experience in representing clients in opposition and appeal proceedings at the European Patent Office.

Qualifications

Patent Attorney

Chartered (UK)
Europe


PHD

The development and evaluation of microparticulate formulations for DNA immunisation

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property Law

OTHER

BPharm

Recognition

IAM Strategy 300 - Leading IP Strategists

Andrew is listed in the IAM Strategy 300 as a leading IP strategist

View recognition online

IAM Patent 1000

Andrew is listed in the IAM Patent 1000 as a leading IP attorney in his field.

View recognition online

MIP Star

Andrew is listed as a MIP Star.

View recognition online

Publications

Mondaq awards HGF for thought leadership in Germany

View publication online

HGF is ranked as a top tier firm in Legal 500 UK 2024

View publication online

Leader's League Rankings 2023

View publication online

IP Stars 2023

View publication online

IAM Patent 1000 2022

View publication online

IAM Strategy 300 2021

View publication online

Drug repurposing: progress, challenges and recommendations - Nature Medicine article on Drug Repurposing

View publication online

Conferences: 2023

November 21st 2023

LSPN Europe 2023

Attended

Event details

Conferences: 2022

September 22nd 2022

BioCap Conference 2022

Attended

Event details

Conferences: 2021

October 7th 2021

The Business of Science Conference 2021

Attended

Event details

CSR

Andrew mentors and contributes to the professional training of Trainee Patent Attorneys within HGF, as well as mentoring and training of IP and technology transfer professionals in other organisations.

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.